Iron oxide nanoparticle targeted chemo-immunotherapy for triple negative breast cancer.
Iron oxide nanoparticle targeted chemo-immunotherapy for triple negative breast cancer.
复制标题
DOI:
10.1016/j.mattod.2021.08.002
复制
发表时间:
2021-11
期刊:
影响因子:
--
通讯作者:
Zhang M
中科院分区:
文献类型:
--
作者:
Mu QG;Lin G;Jeon M;Wang H;Chang FC;Revia RA;Yu J;Zhang M
Triple negative breast cancer is difficult to treat effectively, due to its aggressiveness, drug resistance, and lack of the receptors required for hormonal therapy, particularly at the metastatic stage. Here, we report the development and evaluation of a multifunctional nanoparticle formulation containing an iron oxide core that can deliver doxorubicin, a cytotoxic agent, and polyinosinic:polycytidylic acid (Poly IC), a TLR3 agonist, in a targeted and simultaneous fashion to both breast cancer and dendritic cells. Endoglin-binding peptide (EBP) is used to target both TNBC cells and vasculature epithelia. The nanoparticle demonstrates favorable physicochemical properties and a tumor-specific targeting profile. The nanoparticle induces tumor apoptosis through multiple mechanisms including direct tumor cell killing, dendritic cell-initiated innate and T cell-mediated adaptive immune responses. The nanoparticle markedly inhibits tumor growth and metastasis and substantially extends survival in an aggressive and drug-resistant metastatic mouse model of triple negative breast cancer (TNBC). This study points to a promising platform that may substantially improve the therapeutic efficacy for treating metastatic TNBC.
登录
查看更多内容
影响因子:
3.7
作者:
Bandyopadhyay A;Wang L;Agyin J;Tang Y;Lin S;Yeh IT;De K;Sun LZ
通讯作者:
Sun LZ
影响因子:
10
作者:
Hernandez-Gil, Javier;Cobaleda-Siles, Macarena;Mareque-Rivas, Juan C.
通讯作者:
Mareque-Rivas, Juan C.
影响因子:
14
作者:
Deng, Xiongwei;Cao, Minjun;Zeng, Yi
通讯作者:
Zeng, Yi
影响因子:
82.9
作者:
Fernandez, NC;Lozier, A;Zitvogel, L
通讯作者:
Zitvogel, L
影响因子:
3
作者:
Dehshahri, Ali;Sadeghpour, Hossein;Sheikhsaran, Fatemeh
通讯作者:
Sheikhsaran, Fatemeh